nodes	percent_of_prediction	percent_of_DWPC	metapath
Glimepiride—Coma—Methotrexate—ankylosing spondylitis	0.00469	0.00469	CcSEcCtD
Glimepiride—Weight increased—Triamcinolone—ankylosing spondylitis	0.00444	0.00444	CcSEcCtD
Glimepiride—Weight increased—Methylprednisolone—ankylosing spondylitis	0.00443	0.00443	CcSEcCtD
Glimepiride—Bradycardia—Prednisolone—ankylosing spondylitis	0.00432	0.00432	CcSEcCtD
Glimepiride—Sweating increased—Betamethasone—ankylosing spondylitis	0.00431	0.00431	CcSEcCtD
Glimepiride—Sweating increased—Dexamethasone—ankylosing spondylitis	0.00431	0.00431	CcSEcCtD
Glimepiride—Diabetes mellitus—Methotrexate—ankylosing spondylitis	0.00429	0.00429	CcSEcCtD
Glimepiride—Sweating—Methylprednisolone—ankylosing spondylitis	0.00416	0.00416	CcSEcCtD
Glimepiride—Hepatic failure—Methotrexate—ankylosing spondylitis	0.00415	0.00415	CcSEcCtD
Glimepiride—Visual impairment—Prednisolone—ankylosing spondylitis	0.00409	0.00409	CcSEcCtD
Glimepiride—Weight increased—Betamethasone—ankylosing spondylitis	0.00403	0.00403	CcSEcCtD
Glimepiride—Weight increased—Dexamethasone—ankylosing spondylitis	0.00403	0.00403	CcSEcCtD
Glimepiride—Bradycardia—Triamcinolone—ankylosing spondylitis	0.00398	0.00398	CcSEcCtD
Glimepiride—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.00397	0.00397	CcSEcCtD
Glimepiride—Alanine aminotransferase increased—Prednisone—ankylosing spondylitis	0.00393	0.00393	CcSEcCtD
Glimepiride—Abdominal distension—Prednisone—ankylosing spondylitis	0.00388	0.00388	CcSEcCtD
Glimepiride—Cerebrovascular accident—Methotrexate—ankylosing spondylitis	0.0038	0.0038	CcSEcCtD
Glimepiride—Arrhythmia—Prednisolone—ankylosing spondylitis	0.00379	0.00379	CcSEcCtD
Glimepiride—Sweating increased—Prednisone—ankylosing spondylitis	0.00376	0.00376	CcSEcCtD
Glimepiride—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.00376	0.00376	CcSEcCtD
Glimepiride—Erythema—Prednisolone—ankylosing spondylitis	0.0037	0.0037	CcSEcCtD
Glimepiride—Bradycardia—Betamethasone—ankylosing spondylitis	0.00361	0.00361	CcSEcCtD
Glimepiride—Bradycardia—Dexamethasone—ankylosing spondylitis	0.00361	0.00361	CcSEcCtD
Glimepiride—Weight increased—Prednisone—ankylosing spondylitis	0.00351	0.00351	CcSEcCtD
Glimepiride—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.00349	0.00349	CcSEcCtD
Glimepiride—Vision blurred—Prednisolone—ankylosing spondylitis	0.00348	0.00348	CcSEcCtD
Glimepiride—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.00348	0.00348	CcSEcCtD
Glimepiride—Visual impairment—Betamethasone—ankylosing spondylitis	0.00342	0.00342	CcSEcCtD
Glimepiride—Visual impairment—Dexamethasone—ankylosing spondylitis	0.00342	0.00342	CcSEcCtD
Glimepiride—Erythema—Triamcinolone—ankylosing spondylitis	0.0034	0.0034	CcSEcCtD
Glimepiride—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.00339	0.00339	CcSEcCtD
Glimepiride—Erythema—Methylprednisolone—ankylosing spondylitis	0.00339	0.00339	CcSEcCtD
Glimepiride—Angioedema—Prednisolone—ankylosing spondylitis	0.00338	0.00338	CcSEcCtD
Glimepiride—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00325	0.00325	CcSEcCtD
Glimepiride—Convulsion—Prednisolone—ankylosing spondylitis	0.0032	0.0032	CcSEcCtD
Glimepiride—Hypertension—Prednisolone—ankylosing spondylitis	0.00319	0.00319	CcSEcCtD
Glimepiride—Eosinophilia—Methotrexate—ankylosing spondylitis	0.00319	0.00319	CcSEcCtD
Glimepiride—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.00317	0.00317	CcSEcCtD
Glimepiride—Arrhythmia—Betamethasone—ankylosing spondylitis	0.00317	0.00317	CcSEcCtD
Glimepiride—Bradycardia—Prednisone—ankylosing spondylitis	0.00314	0.00314	CcSEcCtD
Glimepiride—Angioedema—Triamcinolone—ankylosing spondylitis	0.00311	0.00311	CcSEcCtD
Glimepiride—Angioedema—Methylprednisolone—ankylosing spondylitis	0.0031	0.0031	CcSEcCtD
Glimepiride—Erythema—Betamethasone—ankylosing spondylitis	0.00308	0.00308	CcSEcCtD
Glimepiride—Erythema—Dexamethasone—ankylosing spondylitis	0.00308	0.00308	CcSEcCtD
Glimepiride—Pancytopenia—Methotrexate—ankylosing spondylitis	0.00306	0.00306	CcSEcCtD
Glimepiride—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00302	0.00302	CcSEcCtD
Glimepiride—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00299	0.00299	CcSEcCtD
Glimepiride—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00298	0.00298	CcSEcCtD
Glimepiride—Shock—Prednisolone—ankylosing spondylitis	0.00297	0.00297	CcSEcCtD
Glimepiride—Convulsion—Triamcinolone—ankylosing spondylitis	0.00295	0.00295	CcSEcCtD
Glimepiride—Tachycardia—Prednisolone—ankylosing spondylitis	0.00294	0.00294	CcSEcCtD
Glimepiride—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.00294	0.00294	CcSEcCtD
Glimepiride—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00294	0.00294	CcSEcCtD
Glimepiride—Hypertension—Triamcinolone—ankylosing spondylitis	0.00294	0.00294	CcSEcCtD
Glimepiride—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00293	0.00293	CcSEcCtD
Glimepiride—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00292	0.00292	CcSEcCtD
Glimepiride—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00288	0.00288	CcSEcCtD
Glimepiride—Drowsiness—Methotrexate—ankylosing spondylitis	0.00287	0.00287	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.00285	0.00285	CcSEcCtD
Glimepiride—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00283	0.00283	CcSEcCtD
Glimepiride—Angioedema—Betamethasone—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Glimepiride—Angioedema—Dexamethasone—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Glimepiride—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00279	0.00279	CcSEcCtD
Glimepiride—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00277	0.00277	CcSEcCtD
Glimepiride—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00277	0.00277	CcSEcCtD
Glimepiride—Arrhythmia—Prednisone—ankylosing spondylitis	0.00276	0.00276	CcSEcCtD
Glimepiride—Sweating—Methotrexate—ankylosing spondylitis	0.00275	0.00275	CcSEcCtD
Glimepiride—Shock—Triamcinolone—ankylosing spondylitis	0.00273	0.00273	CcSEcCtD
Glimepiride—Insomnia—Prednisolone—ankylosing spondylitis	0.00273	0.00273	CcSEcCtD
Glimepiride—Shock—Methylprednisolone—ankylosing spondylitis	0.00272	0.00272	CcSEcCtD
Glimepiride—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00271	0.00271	CcSEcCtD
Glimepiride—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00271	0.00271	CcSEcCtD
Glimepiride—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00271	0.00271	CcSEcCtD
Glimepiride—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00271	0.00271	CcSEcCtD
Glimepiride—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.0027	0.0027	CcSEcCtD
Glimepiride—Erythema—Prednisone—ankylosing spondylitis	0.00269	0.00269	CcSEcCtD
Glimepiride—Malnutrition—Prednisone—ankylosing spondylitis	0.00269	0.00269	CcSEcCtD
Glimepiride—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00268	0.00268	CcSEcCtD
Glimepiride—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.00268	0.00268	CcSEcCtD
Glimepiride—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00268	0.00268	CcSEcCtD
Glimepiride—Convulsion—Dexamethasone—ankylosing spondylitis	0.00267	0.00267	CcSEcCtD
Glimepiride—Convulsion—Betamethasone—ankylosing spondylitis	0.00267	0.00267	CcSEcCtD
Glimepiride—Hypertension—Dexamethasone—ankylosing spondylitis	0.00266	0.00266	CcSEcCtD
Glimepiride—Hypertension—Betamethasone—ankylosing spondylitis	0.00266	0.00266	CcSEcCtD
Glimepiride—Anxiety—Betamethasone—ankylosing spondylitis	0.00262	0.00262	CcSEcCtD
Glimepiride—Anxiety—Dexamethasone—ankylosing spondylitis	0.00262	0.00262	CcSEcCtD
Glimepiride—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00259	0.00259	CcSEcCtD
Glimepiride—Hepatitis—Methotrexate—ankylosing spondylitis	0.00258	0.00258	CcSEcCtD
Glimepiride—Vision blurred—Prednisone—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Glimepiride—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Glimepiride—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Glimepiride—Insomnia—Triamcinolone—ankylosing spondylitis	0.00251	0.00251	CcSEcCtD
Glimepiride—Insomnia—Methylprednisolone—ankylosing spondylitis	0.0025	0.0025	CcSEcCtD
Glimepiride—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Glimepiride—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Glimepiride—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Glimepiride—Visual impairment—Methotrexate—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Glimepiride—Anaemia—Prednisone—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Glimepiride—Shock—Dexamethasone—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Glimepiride—Shock—Betamethasone—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Glimepiride—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00247	0.00247	CcSEcCtD
Glimepiride—Agitation—Prednisone—ankylosing spondylitis	0.00247	0.00247	CcSEcCtD
Glimepiride—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00247	0.00247	CcSEcCtD
Glimepiride—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00247	0.00247	CcSEcCtD
Glimepiride—Tachycardia—Betamethasone—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Glimepiride—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Glimepiride—Angioedema—Prednisone—ankylosing spondylitis	0.00245	0.00245	CcSEcCtD
Glimepiride—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00244	0.00244	CcSEcCtD
Glimepiride—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.00244	0.00244	CcSEcCtD
Glimepiride—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00244	0.00244	CcSEcCtD
Glimepiride—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00243	0.00243	CcSEcCtD
Glimepiride—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00243	0.00243	CcSEcCtD
Glimepiride—Anorexia—Dexamethasone—ankylosing spondylitis	0.0024	0.0024	CcSEcCtD
Glimepiride—Anorexia—Betamethasone—ankylosing spondylitis	0.0024	0.0024	CcSEcCtD
Glimepiride—Urticaria—Prednisolone—ankylosing spondylitis	0.0024	0.0024	CcSEcCtD
Glimepiride—Fatigue—Triamcinolone—ankylosing spondylitis	0.00239	0.00239	CcSEcCtD
Glimepiride—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00239	0.00239	CcSEcCtD
Glimepiride—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00236	0.00236	CcSEcCtD
Glimepiride—Hypotension—Betamethasone—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Glimepiride—Hypotension—Dexamethasone—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Glimepiride—Convulsion—Prednisone—ankylosing spondylitis	0.00233	0.00233	CcSEcCtD
Glimepiride—Hypertension—Prednisone—ankylosing spondylitis	0.00232	0.00232	CcSEcCtD
Glimepiride—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00229	0.00229	CcSEcCtD
Glimepiride—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Glimepiride—Anxiety—Prednisone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Glimepiride—Insomnia—Dexamethasone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Glimepiride—Insomnia—Betamethasone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Glimepiride—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00226	0.00226	CcSEcCtD
Glimepiride—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00226	0.00226	CcSEcCtD
Glimepiride—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00226	0.00226	CcSEcCtD
Glimepiride—Malnutrition—Methotrexate—ankylosing spondylitis	0.00225	0.00225	CcSEcCtD
Glimepiride—Erythema—Methotrexate—ankylosing spondylitis	0.00225	0.00225	CcSEcCtD
Glimepiride—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Glimepiride—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Glimepiride—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00222	0.00222	CcSEcCtD
Glimepiride—Urticaria—Triamcinolone—ankylosing spondylitis	0.0022	0.0022	CcSEcCtD
Glimepiride—Urticaria—Methylprednisolone—ankylosing spondylitis	0.0022	0.0022	CcSEcCtD
Glimepiride—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Glimepiride—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Glimepiride—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Glimepiride—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00217	0.00217	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00217	0.00217	CcSEcCtD
Glimepiride—Fatigue—Dexamethasone—ankylosing spondylitis	0.00217	0.00217	CcSEcCtD
Glimepiride—Fatigue—Betamethasone—ankylosing spondylitis	0.00217	0.00217	CcSEcCtD
Glimepiride—Shock—Prednisone—ankylosing spondylitis	0.00216	0.00216	CcSEcCtD
Glimepiride—Tachycardia—Prednisone—ankylosing spondylitis	0.00214	0.00214	CcSEcCtD
Glimepiride—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00212	0.00212	CcSEcCtD
Glimepiride—Vision blurred—Methotrexate—ankylosing spondylitis	0.00212	0.00212	CcSEcCtD
Glimepiride—Anorexia—Prednisone—ankylosing spondylitis	0.00209	0.00209	CcSEcCtD
Glimepiride—Anaemia—Methotrexate—ankylosing spondylitis	0.00208	0.00208	CcSEcCtD
Glimepiride—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Glimepiride—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Glimepiride—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00206	0.00206	CcSEcCtD
Glimepiride—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00206	0.00206	CcSEcCtD
Glimepiride—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Glimepiride—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Glimepiride—Leukopenia—Methotrexate—ankylosing spondylitis	0.00201	0.00201	CcSEcCtD
Glimepiride—Urticaria—Dexamethasone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Glimepiride—Urticaria—Betamethasone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Glimepiride—Dizziness—Prednisolone—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Glimepiride—Asthenia—Triamcinolone—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Glimepiride—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Glimepiride—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Glimepiride—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Glimepiride—Insomnia—Prednisone—ankylosing spondylitis	0.00198	0.00198	CcSEcCtD
Glimepiride—Paraesthesia—Prednisone—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
Glimepiride—Pruritus—Triamcinolone—ankylosing spondylitis	0.00196	0.00196	CcSEcCtD
Glimepiride—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00196	0.00196	CcSEcCtD
Glimepiride—Convulsion—Methotrexate—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Glimepiride—Dyspepsia—Prednisone—ankylosing spondylitis	0.00193	0.00193	CcSEcCtD
Glimepiride—Decreased appetite—Prednisone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Glimepiride—Rash—Prednisolone—ankylosing spondylitis	0.0019	0.0019	CcSEcCtD
Glimepiride—Dermatitis—Prednisolone—ankylosing spondylitis	0.0019	0.0019	CcSEcCtD
Glimepiride—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
Glimepiride—Fatigue—Prednisone—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
Glimepiride—Headache—Prednisolone—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
Glimepiride—Confusional state—Methotrexate—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Glimepiride—Dizziness—Triamcinolone—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Glimepiride—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Glimepiride—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Glimepiride—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Glimepiride—Asthenia—Betamethasone—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Glimepiride—Asthenia—Dexamethasone—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Glimepiride—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Glimepiride—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Glimepiride—Nausea—Prednisolone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Glimepiride—Pruritus—Dexamethasone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Glimepiride—Pruritus—Betamethasone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Glimepiride—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00177	0.00177	CcSEcCtD
Glimepiride—Vomiting—Triamcinolone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Glimepiride—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Glimepiride—Rash—Triamcinolone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Glimepiride—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Glimepiride—Anorexia—Methotrexate—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Glimepiride—Rash—Methylprednisolone—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Glimepiride—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Glimepiride—Urticaria—Prednisone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Glimepiride—Headache—Triamcinolone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Glimepiride—Headache—Methylprednisolone—ankylosing spondylitis	0.00173	0.00173	CcSEcCtD
Glimepiride—Abdominal pain—Prednisone—ankylosing spondylitis	0.00173	0.00173	CcSEcCtD
Glimepiride—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Glimepiride—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Glimepiride—Hypotension—Methotrexate—ankylosing spondylitis	0.00171	0.00171	CcSEcCtD
Glimepiride—Dizziness—Betamethasone—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Glimepiride—Dizziness—Dexamethasone—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Glimepiride—Insomnia—Methotrexate—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Glimepiride—Nausea—Triamcinolone—ankylosing spondylitis	0.00165	0.00165	CcSEcCtD
Glimepiride—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00165	0.00165	CcSEcCtD
Glimepiride—Nausea—Methylprednisolone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Glimepiride—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Glimepiride—Somnolence—Methotrexate—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Glimepiride—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Glimepiride—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Glimepiride—Vomiting—Dexamethasone—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Glimepiride—Vomiting—Betamethasone—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Glimepiride—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Glimepiride—Rash—Dexamethasone—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Glimepiride—Rash—Betamethasone—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Glimepiride—Dermatitis—Betamethasone—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Glimepiride—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Glimepiride—Fatigue—Methotrexate—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Glimepiride—Headache—Dexamethasone—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Glimepiride—Headache—Betamethasone—ankylosing spondylitis	0.00158	0.00158	CcSEcCtD
Glimepiride—Asthenia—Prednisone—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Glimepiride—Pruritus—Prednisone—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Glimepiride—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Glimepiride—Diarrhoea—Prednisone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Glimepiride—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Glimepiride—Nausea—Betamethasone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Glimepiride—Nausea—Dexamethasone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Glimepiride—Urticaria—Methotrexate—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Glimepiride—Dizziness—Prednisone—ankylosing spondylitis	0.00145	0.00145	CcSEcCtD
Glimepiride—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00145	0.00145	CcSEcCtD
Glimepiride—Vomiting—Prednisone—ankylosing spondylitis	0.00139	0.00139	CcSEcCtD
Glimepiride—Rash—Prednisone—ankylosing spondylitis	0.00138	0.00138	CcSEcCtD
Glimepiride—Dermatitis—Prednisone—ankylosing spondylitis	0.00138	0.00138	CcSEcCtD
Glimepiride—Headache—Prednisone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Glimepiride—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Glimepiride—Asthenia—Methotrexate—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Glimepiride—Nausea—Prednisone—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Glimepiride—Pruritus—Methotrexate—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Glimepiride—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00125	0.00125	CcSEcCtD
Glimepiride—Dizziness—Methotrexate—ankylosing spondylitis	0.00121	0.00121	CcSEcCtD
Glimepiride—Vomiting—Methotrexate—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Glimepiride—Rash—Methotrexate—ankylosing spondylitis	0.00116	0.00116	CcSEcCtD
Glimepiride—Dermatitis—Methotrexate—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Glimepiride—Headache—Methotrexate—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Glimepiride—Nausea—Methotrexate—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
